Hologic
 |
|
| Public | |
| Traded as |
NASDAQ: HOLX S&P 500 Component |
| Industry | Medical products |
| Founded | 1985 |
| Headquarters | Marlborough, Massachusetts, U.S. |
|
Key people
|
Stephen P. MacMillan President and CEO |
| Revenue | US$ 2.83 billion (2016) |
| US$ 0.5 billion (2016) | |
| US$ 0.3 billion (2016) | |
|
Number of employees
|
~5,300 |
| Website | www.hologic.com |
Hologic, Inc. is a developer, manufacturer and supplier of diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, gynecological surgical, and skeletal health. Its major products include the Selenia Dimension mammography system, the Discovery and Horizon bone densitometers, the NovaSure endometrial ablation device, the ThinPrep pap test, and the Aptima, Cervista, and Prodesse diagnostic assays. While historically the Company was focused on women's health, expansion into the molecular diagnostics space has resulted in the Company's rebranding from "The Women's Health Company" to its current tagline, "The Science of Sure".
On May 20, 2007, Hologic announced a merger (via a cash and stock transaction) with the Cytyc Corporation to create a $10 billion women's healthcare company with over $1 billion in projected annual sales.
On April 30, 2012, Hologic announced a merger with Gen-Probe for about $3.72 billion by cash.
On February 14, 2017, it was announced that Hologic had acquired Cynosure, Inc., a leading manufacturer and distributor of aesthetic medical devices. The transaction was complete on March 22, 2017.
In late November 2013, activist investor Carl Icahn disclosed a 12.5% stake in the company. Subsequently, the company adopted a poison pill to prevent a hostile takeover. In negotiations with the Company's board of directors, two additional directors backed by Mr. Icahn were added to the board, each managing directors of Icahn holding companies. The directors relinquished their positions in March 2016; by April 2016, Icahn's share in the Company had fallen below 5%.
...
Wikipedia